Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-chloro-2,5-dimethoxypyrimidine

US9000160B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9000160-B2
Application numberUS-201314022766-A
CountryUS
Kind codeB2
Filing dateSep 10, 2013
Priority dateSep 14, 2012
Publication dateApr 7, 2015
Grant dateApr 7, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

2-Amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]pyrimidines are manufactured from 4-chloro-2,5-dialkoxypyrimidines in a process that avoids hydrazine and cyanogen halide.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for the preparation of 2-amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]-pyrimidines of the formula (I), wherein R is C 1 -C 4 alkyl comprising: i) contacting a 4-chloro-2,5-dialkoxypyrimidine of the formula wherein R is as previously defined with a salt of cyanamide in a polar aprotic solvent to provide a 2,5-dialkoxy-4-cyanoaminopyrimidine of the formula in which R is as previously defined; ii) contacting the 2,5-dialkoxy-4-cyanoaminopyrimidine with either hydroxylamine as a free base or hydroxylamine salt in the presence of a base to provide a 2,5-dialkoxy-4-hydroxyguanidinylpyrimidine of the formula wherein R is as previously defined; and iii) cyclizing the 2,5-dialkoxy-4-hydroxyguanidinylpyrimidine by treating with an alkyl chloroformate to provide the 2-amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]pyrimidine. 2. The process of claim 1 , wherein R is CH 3 . 3. The process of claim 1 , wherein the 2,5-dialkoxy-4-hydroxyguanidinyl-pyrimidine of step ii) is used without isolation to prepare the 2-amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]pyrimidine in step iii). 4. The process of claim 1 , wherein the salt of cyanamide is an alkali metal salt or alkaline earth metal salt. 5. The process of claim 1 , wherein the salt of cyanamide is sodium hydrogen cyanamide. 6. The process of claim 1 , wherein the polar aprotic solvent of (i) is acetonitrile or N-methyl-2-pyrrolidinone. 7. The process of claim 1 , wherein (i) is performed at a temperature of from about 0° C. to about 60° C. 8. The process of claim 1 , wherein the free base of hydroxylamine salt of (ii) is a sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, or a trialkylamine salt. 9. The process of claim 1 , wherein (ii) is performed in a polar solvent. 10. The process of claim 9 , wherein the solvent is methanol, ethyl acetate, or acetonitrile. 11. The process of claim 1 , wherein (ii) is performed at a temperature of from about 0° C. to about 80° C. 12. The process of claim 1 , wherein the alkylchloroformate of (iii) is a methyl chloroformate. 13. The process of claim 1 , wherein (iii) is performed in the presence of a base. 14. The process of claim 13 , wherein the base is sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, or triethylamine. 15. The process of claim 1 , wherein (iii) is performed at a temperature of from about 45° C. to about 100° C. 16. The process of claim 1 , wherein (iii) is performed in a polar aprotic solvent. 17. The process of claim 16 , wherein the solvent is ethyl acetate or acetonitrile. 18. A process for the preparation of 2-amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]-pyrimidines of the formula (I), wherein R is C 1 -C 4 alkyl comprising: cyclizing a 2,5-dialkoxy-4-hydroxyguanidinylpyrimidine of the formula wherein R is as previously defined; by treating with an alkyl chloroformate to provide the 2-amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]pyrimidine. 19. The process of claim 18 , wherein the 2,5-dialkoxy-4-hydroxyguanidinylpyrimidine is formed by contacting a 2,5-dialkoxy-4-cyanoaminopyrimidine of the formula in which R is as previously defined with either hydroxylamine as a free base or hydroxylamine salt in the presence of a base to provide a 2,5-dialkoxy-4-hydroxyguanidinylpyrimidine. 20. A compound of the formula in which R represents C 1 -C 4 alkyl. 21. A compound of the formula in which R represents C 1 -C 4 alkyl.

Assignees

Inventors

Classifications

  • C07D487/04Primary

    Ortho-condensed systems · CPC title

  • C07D239/52Primary

    Two oxygen atoms · CPC title

  • Propene · CPC title

  • with metals or metal-containing compounds, not provided for in groups C08F4/653 - C08F4/656 · CPC title

  • Pretreating with non-metals or metal-free compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9000160B2 cover?
2-Amino-5,8-dialkoxy[1,2,4]-triazolo[1,5-c]pyrimidines are manufactured from 4-chloro-2,5-dialkoxypyrimidines in a process that avoids hydrazine and cyanogen halide.
Who is the assignee on this patent?
Bland Douglas C, Roth Gary, Bott Craig, and 3 more
What technology area does this patent fall under?
Primary CPC classification C07D487/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).